Visakhapatnam: Eisai Pharma, a noted human health care pharmaceutical company, announced its plans to establish a new global capability center (GCC) i.

Eisai Pharma is set to establish a new Global Capability Center (GCC) in Visakhapatnam, aiming to boost its digital transformation efforts in India.

Eisai Pharma, a leading human health care (hhc) pharmaceutical company with a global footprint, announced on Wednesday its plan to establish a new Global Capability Center (GCC) in Visakhapatnam ...

Senior Eisai executives have issued the following statements. Shaeed Chowdhury, Medical Director, Eisai UK and Ireland, said, “Alzheimer’s is a progressive disease that worsens over time, robbing ...

Eisai Limited, a leading research and development-based pharmaceutical company specializing in neurology and oncology, has expanded the footprint of its Canadian Headquarters in Mississauga, Ontario.

The latest international Eisai Co Ltd news and views from Reuters - one of the world's largest news agencies ...

Eisai has scaled down its sales expectations for Alzheimer's disease drug Leqembi after sluggish sales growth in the first half of the current fiscal year.

Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on ...

SAN FRANCISCO--An experimental Alzheimer’s disease drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain ...

Review the current Eisai Co Ltd (4523:XTKS) dividend yield and history to decide if 4523 is the best investment for you.

Attorney Emily J. Perkins has joined the law firm of Lorch Naville Ward LLC at 506 State St. in New Albany as a junior partner who will focus on family law. Perkins earned an undergraduate degree ...